Result of General Meeting

RNS Number : 1727Y

Omega Diagnostics Group PLC

17 December 2010

 



17 December 2010

OMEGA DIAGNOSTICS GROUP PLC

("OMEGA DIAGNOSTICS" OR THE "COMPANY")

Result of General Meeting

Omega Diagnostics, the AIM-listed medical diagnostics company, announces that at today's General Meeting of the Company all resolutions were duly passed. Shareholders have approved the acquisition of the business and certain assets of the IVD Business of Allergopharma Joachim Ganzer KG, a leading European allergy testing business, for consideration of €6.0 million together with a placing of 64,583,350 new ordinary shares at 12 pence per share to raise GBP7.75 million before expenses.  The Acquisition constitutes a reverse acquisition under the AIM Rules for Companies.  Accordingly, the Company has applied for re admission of the Enlarged Share Capital to trading on AIM. It is anticipated that 4,999,950 of the Placing Shares will be admitted to trading on 20 December 2010 and 59,583,400 of the Placing Shares will be admitted to trading on 21 December 2010 along with re admission of the existing ordinary share capital as required under the AIM Rules for Companies.

Defined terms used in this announcement shall have the same meaning as ascribed to them in the Company's announcement of 17 November 2010.

For further information please contact:

Omega Diagnostics Group plc	Tel: [phone]
Andrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director	www.omegadiagnostics.com
Cenkos Securities plc	Tel: [phone]
Ian Soanes
Elizabeth Bowman
Walbrook PR Limited	Tel: [phone]
Fiona Henson
Helen Westaway
Paul Cornelius	Tel: [phone]

 

END

 

 

MSCKDLBFBLFEFBB